Commits to BGSU Novosad committed to Bowling Green, Pete Thamel of ESPN.com reports. Impact Novosad entered the transfer portal after three seasons at Oregon. He served as a backup in all three ...

The Health and Life Sciences Village hosts “Tea Time” every Thursday, where tea and snacks are placed on the table for ...

BALTIMORE, MD, UNITED STATES, March 10, 2026 /EINPresswire.com/ — Scipher Medicine and Senelix today announced a strategic collaboration to incorporate Scipher’s AI network platform to de-risk and ...

COLUMBUS, Ohio — As news of Ted Carter 's resignation as Ohio State University's president spread across campus, students went about their days as normal, walking to and from class, talking with ...

Until now, conventional 3D cell cultures have often been either too rigid or too unstable to realistically reproduce the ...

Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7 ...

Shares in BridgeBio were ticking up today after it revealed data from its phase 3 trial of infigratinib in achondroplasia, the most common form of dwarfism, that could form the basis of regulatory ...

The draft syllabus highlights the "rich civilisational history of the Indian subcontinent" New Delhi: The National Council of Educational Research and Training (NCERT) is set to release new Class 9 ...

NEW YORK - Nuvation Bio Inc. (NYSE:NUVB) has finalized a protocol amendment to its ongoing SIGMA study of safusidenib, expanding it from a Phase 2 to a Phase 3 trial, according to a company press ...

New Delhi: The new NCERT (National Council of Educational Research and Training) social science textbooks for Class 9, set to be released in March will focus on indigenous intellectual and cultural ...

YD Bio maintains zero debt on its balance sheet with a P/E ratio of -9.3, while posting a 16% price return over the past year. Investors seeking deeper financial insights and additional metrics can ...

Company plans to initiate a Phase 1 clinical study by 1H2026 and share data in 2027 NEOK Bio, Inc., an oncology therapeutics company focused on the development of novel antibody drug conjugates (ADCs) ...